A cytotoxic ribonuclease targeting specific transfer RNA anticodons

Science

Volumn 283, Issue 5410, 1999, Pages 2097-2100

  Ogawa, T ^a   Tomita, K ^b,c   Ueda, T ^b   Watanabe, K ^b   Uozumi, T ^a   Masaki, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c INST DE BIOL MOLEC DES PLANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE TRANSFER RNA; ASPARTIC ACID TRANSFER RNA; COLICIN; HISTIDINE TRANSFER RNA; QUEUINE; RIBONUCLEASE; TRANSFER RNA; TYROSINE TRANSFER RNA;

ANTICODON; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ESCHERICHIA COLI; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS INHIBITION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0033605708     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.283.5410.2097     Document Type: Article

References (43)

1. I. G. Wool, A. Glück, Y. Endo, Trends Biochem. Sci. 17, 266 (1992).
2. C. M. Bowman, J. E. Dahlberg, T. Ikemura, J. Konisky, M. Nomura, Proc. Natl. Acad. Sci. U.S.A. 68, 964 (1971); A. E. Dahlberg and J. E. Dahlberg, ibid. 72, 2940 (1975); R. A. Baan et al., FEBS Lett. 71, 351 (1976).
3. C. M. Bowman, J. E. Dahlberg, T. Ikemura, J. Konisky, M. Nomura, Proc. Natl. Acad. Sci. U.S.A. 68, 964 (1971); A. E. Dahlberg and J. E. Dahlberg, ibid. 72, 2940 (1975); R. A. Baan et al., FEBS Lett. 71, 351 (1976).
4. C. M. Bowman, J. E. Dahlberg, T. Ikemura, J. Konisky, M. Nomura, Proc. Natl. Acad. Sci. U.S.A. 68, 964 (1971); A. E. Dahlberg and J. E. Dahlberg, ibid. 72, 2940 (1975); R. A. Baan et al., FEBS Lett. 71, 351 (1976).
5. M. Mock and A. P. Pugsley, J. Bacteriol. 150, 1069 (1982).
6. K. S. Jakes, in Molecular Action of Toxins and Viruses, P. Cohen and S. van Heyningen, Eds. (Elsevier, Amsterdam, 1982). pp. 131-167; A. P. Pugsley and B. Oudega, in Plasmids: A Practical Approach, K. C. Hardy, Ed. (IRL, Oxford, UK, 1987), pp. 105-161.
7. K. S. Jakes, in Molecular Action of Toxins and Viruses, P. Cohen and S. van Heyningen, Eds. (Elsevier, Amsterdam, 1982). pp. 131-167; A. P. Pugsley and B. Oudega, in Plasmids: A Practical Approach, K. C. Hardy, Ed. (IRL, Oxford, UK, 1987), pp. 105-161.
8. H. Masaki, S. Yajima, A. Akutsu-Koide, T. Ohta, T. Uozumi, in Bacteriocins, Microcins and Lantibiotics, R. James, C. Lazdunski, F. Pattus, Eds. (Springer-Verlag, Berlin, 1992), pp. 379-395; P. C. K. Lau, M. Parsons, T. Uchimura, in Bacteriocins, Microcins and Lantibiotics, R. James, C. Lazdunski, F. Pattus, Eds. (Springer-Verlag, Berlin, 1992), pp. 353-378; R. James, C. Kleanthous, G. R. Moore, Microbiology 142, 1569 (1996).
9. H. Masaki, S. Yajima, A. Akutsu-Koide, T. Ohta, T. Uozumi, in Bacteriocins, Microcins and Lantibiotics, R. James, C. Lazdunski, F. Pattus, Eds. (Springer-Verlag, Berlin, 1992), pp. 379-395; P. C. K. Lau, M. Parsons, T. Uchimura, in Bacteriocins, Microcins and Lantibiotics, R. James, C. Lazdunski, F. Pattus, Eds. (Springer-Verlag, Berlin, 1992), pp. 353-378; R. James, C. Kleanthous, G. R. Moore, Microbiology 142, 1569 (1996).
10. H. Masaki, S. Yajima, A. Akutsu-Koide, T. Ohta, T. Uozumi, in Bacteriocins, Microcins and Lantibiotics, R. James, C. Lazdunski, F. Pattus, Eds. (Springer-Verlag, Berlin, 1992), pp. 379-395; P. C. K. Lau, M. Parsons, T. Uchimura, in Bacteriocins, Microcins and Lantibiotics, R. James, C. Lazdunski, F. Pattus, Eds. (Springer-Verlag, Berlin, 1992), pp. 353-378; R. James, C. Kleanthous, G. R. Moore, Microbiology 142, 1569 (1996).
11. A. Akutsu, H. Masaki, T. Ohta, J. Bacteriol. 171, 6430 (1989). GenBank accession number X63621.
12. P. C. K. Lau and J. A. Condie, Mol. Gen. Gener. 217, 269 (1989).
13. The plasmid producing E5-CRD and ImmE5 was constructed as follows. A Nco 1 site (CCATGG) was introduced into the initiation codon of the colE3 gene of pSH357 [H. Masaki, A. Akutsu, T. Uozumi, T. Ohta, Gene 107, 133 (1991)]. and the colE3-immE3 segment from this Nco 1 site to the Bcl 1 (TGATCA) site was replaced with a polymerase chain reaction (PCR)-amplified ColE5-099 DNA fragment, giving rise to plasmid pTO501, which produces the E5-CRD/ImmE5 complex in response to SOS inducers. For this purpose, an Nco 1 site was created at the 5′ end of the PCR fragment in such a way that the Asp at the 116th residue from the COOH-terminus of E5 was changed to an fMet, where the ATG is within the Nco 1 site. The termination codon of immE5 was changed to TGA to create a Bcl 1 site at the 3′ end of the PCR fragment.
14. 2-terminal sequences of both ImmE5 proteins were identical and lacked fMet. Through similar construction, E3-CRD was produced from the truncated co/E3 gene encoding the COOH-terminal 110 amino acids plus an fMet, and the final product was confirmed to lack fMet.
15. 2, 50 mM KCl, and 1 mM dithiothreitol.
16. T. Ogawa et al., data not shown.
17. S. Ohno and K. Imahori, J. Biochem. 84, 1637 (1978).
18. H. Donis-Keller, Nucleic Acids Res. 8, 3133 (1980).
19. Figure 2B suggests almost the same size for the E3 fragment and the minor RNA band by E5-CRD, but in fact, just the 5′ end was not determined in the sequencing of the E5-CRD minor band (11). The new high-resolution gel suggests that the E5-CRD minor band is 1 base smaller (48 bases?) than the major E3 fragment (49 bases). The 3′ next sequence of the E3-sensitive site, A50-G49, is G49-U48 (numbers being from the 3′ end) in 16S rRNA. If E5-CRD preferentially cleaves this GU in 165 rRNA, this interestingly resembles the cleavage site, GU (QU), within the E5-sensitive tRNA anticodons (Fig. 3B).
20. Preliminary data were presented at the 24th Symposium on Nucleic Acids Chemistry (Tokyo): H. Masaki et al., Nucleic Acids Symp. Ser. 37, 287 (1997).
21. H. Kasai et al., Biochemistry 14, 4198 (1975); S. Noguchi, Y. Nishimura, Y. Hirota, S. Nishimura, J. Biol. Chem. 257, 6544 (1982); S. Nishimura, Prog. Nucleic Add Res. Mol. Biol. 28, 49 (1983).
22. H. Kasai et al., Biochemistry 14, 4198 (1975); S. Noguchi, Y. Nishimura, Y. Hirota, S. Nishimura, J. Biol. Chem. 257, 6544 (1982); S. Nishimura, Prog. Nucleic Add Res. Mol. Biol. 28, 49 (1983).
23. H. Kasai et al., Biochemistry 14, 4198 (1975); S. Noguchi, Y. Nishimura, Y. Hirota, S. Nishimura, J. Biol. Chem. 257, 6544 (1982); S. Nishimura, Prog. Nucleic Add Res. Mol. Biol. 28, 49 (1983).
24. 2. The DNA probe for the 3′ terminal fragment of 16S rRNA was a 23-mer probe.
25. V. Cameron and O. C. Uhlenbeck, Biochemistry 16, 5120 (1977).
26. D. P. Morse and B. L. Bass, ibid. 36, 8429 (1997).
27. Escherichia coli K12 strain JE7338 (F+ tsx purE lac str) and its tgt (TGT-defective) mutant, JE7339, were obtained from the Genetic Stock Research Center, NIG, Japan. A spontaneous btuB (receptor-defective) mutant of JE7338 was isolated with colicin E3, and its resistance to E3, E5, and phage BF23 was confirmed.
28. Colicin E3 was purified according to H. Masaki and T. Ohta [J. Mol. Biol. 182, 217 (1985)]. Colicin E5 was partially purified from F. coli K12 RR1(ColE5-099) cells as in the case of the E5-CRD/ImmE5 complex up to the DEAE-TOYOPEARL column chromatography (9). Its purity was densitometrically estimated.
29. K. Reuter, R. Slany, F. Ullrich, H. Kersten, J. Bacteriol. 173, 2256 (1991).
30. P. Blackburn and S. Moore, Enzymes 15, 317 (1982); J. Steyaert, K. Hallenga, L. Wyns, P. Stanssens, Biochemistry 29, 9064 (1990).
31. P. Blackburn and S. Moore, Enzymes 15, 317 (1982); J. Steyaert, K. Hallenga, L. Wyns, P. Stanssens, Biochemistry 29, 9064 (1990).
32. J. A. Gerlt, in Nucleases, S. M. Linn, R. S. Lloyd, R. J. Roberts, Eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, ed. 2, 1993), pp. 1-34.
33. M. Amitsur, R. Levitz, G. Kaufmann, EMBO J. 6, 2499 (1987).
34. S. K. Saxena, S. M. Rybak, R. T. Davey Jr., R. J. Youle, E. J. Ackerman, J. Biol. Chem. 267, 21982 (1992).
35. J. Sagara et al., Nucleic Acids Res. 26, 1974 (1998). We recently confirmed that synthetic RNAs devoid of base modifications are sensitive to E5-CRD as well (T. Ogawa et al., in preparation).
36. J. Sagara et al., Nucleic Acids Res. 26, 1974 (1998). We recently confirmed that synthetic RNAs devoid of base modifications are sensitive to E5-CRD as well (T. Ogawa et al., in preparation).
37. Y. Nakamura, K. Ito, L. A. Isaksson, Cell 87, 147 (1996); K. Ito, M. Uno, Y. Nakamura, Proc. Natl. Acad. Sci. U.S.A. 95, 8165 (1998).
38. Y. Nakamura, K. Ito, L. A. Isaksson, Cell 87, 147 (1996); K. Ito, M. Uno, Y. Nakamura, Proc. Natl. Acad. Sci. U.S.A. 95, 8165 (1998).
39. It was known that there is a great discrepancy between the RNA degradation and ribosorne inactivation activities of the E3-T2A fragment (almost the same as E3-CRD). Usually about 1 μg and 1 ng of E3-T2A were used for RNAs and ribosomes, respectively (12). Because the RNA degradation activity of ES-CRD was in fact higher than that of E3-CRD, the discrepancy of the concentrations used was reduced to about two orders of magnitude.
40. Y. Kuchino, N. Hanyu, S. Nishimura, Methods Enzymol. 155, 379 (1987); G. Keith, Biochimie 77, 142 (1995). Samples were developed on Avicel SF glass plates (10 cm by 10 cm) with the following solvent systems: first dimension, isobutyric acid/ammonia/water (66:1:33, v/v/v); second dimension in a and b, isopropanol/concentrated HCl/water (70:15:15, v/v/v); and in c, 100 ml of 0.1 M sodium phosphate buffer (pH 6.8) + 60 g of ammonium sulfate + 2 ml of n-propanol.
41. Y. Kuchino, N. Hanyu, S. Nishimura, Methods Enzymol. 155, 379 (1987); G. Keith, Biochimie 77, 142 (1995). Samples were developed on Avicel SF glass plates (10 cm by 10 cm) with the following solvent systems: first dimension, isobutyric acid/ammonia/water (66:1:33, v/v/v); second dimension in a and b, isopropanol/concentrated HCl/water (70:15:15, v/v/v); and in c, 100 ml of 0.1 M sodium phosphate buffer (pH 6.8) + 60 g of ammonium sulfate + 2 ml of n-propanol.
42. P. Chomczynski and N. Sacchi, Anal. Biochem. 162, 156 (1987).
43. We thank I. Nitta and M. Sano for technical advice; M. Hidaka, A. Nakamura, Y. Gunji, and J. Sagara for helpful discussions; and D. P. Brunner for ColE5-099. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture.